Skip to content
September 28, 2023


Investment information for the new generation

Medexus Pharma (MDP.T) – Investor Roundtable

Welcome to Equity.Guru’s Roundtable where our writers weigh in on the pros and cons of a spotlight company, break out where they see value, and help you avoid public markets pitfalls.

Today, we focus on Medexus Pharma (MDP.T), a Canadian specialty pharma firm bringing new therapeutic drugs to the Canadian market for use in such areas as rheumatology, auto-immune disease, specialty oncology, allergy, and pediatric diseases.



Related Posts

More on

Leave a Reply

Your email address will not be published. Required fields are marked *